Post Resch Tallon Group »

Cardiff Oncology shares owned by Post Resch Tallon Group

Quarter-by-quarter ownership of Cardiff Oncology (CRDF) shares owned by Post Resch Tallon Group from 13F filings

Historical chart of Post Resch Tallon Group investment in Cardiff Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cardiff Oncology held by Post Resch Tallon Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiff Oncology by Post Resch Tallon Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $46k 23k 2.06

More positions owned by Post Resch Tallon Group

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 3000 Etf (IWV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadstone Net Lease (BNL)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p Scp Etf (IJR)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exelixis (EXEL)
Spdr Series Trust Portfolio S&p400 (SPMD)
Ark Etf Tr Innovation Etf (ARKK)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Metropcs Communications (TMUS)
Ishares Tr Rus Tp200 Gr Etf (IWY)

View all positions for Post Resch Tallon Group

Top funds holding Cardiff Oncology

BlackRock
Vanguard Group
Laurion Capital Management
Pfizer
William Blair $ Company
Acorn Capital Advisors
Geode Capital Management
State Street Corporation
UBS Group
Morgan Stanley
Putnam Fl Investment Management
Northern Trust
Goldman Sachs Group
Bank of New York Mellon
Susquehanna International

View all funds holding Cardiff Oncology